Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02996006
Other study ID # TJ-liver-200804
Secondary ID
Status Completed
Phase N/A
First received December 12, 2016
Last updated December 16, 2016
Start date November 2009

Study information

Verified date December 2016
Source Tongji Hospital
Contact n/a
Is FDA regulated No
Health authority China: Ministry of Health
Study type Observational [Patient Registry]

Clinical Trial Summary

This observational study introduced an new advanced bleeding control strategy during complex liver resection.This newly described "stepwise vascular control" technique was efficacious and feasible to control intra-operative bleeding in complex hepatectomy involving second hepatic hilum and retro-hepatic inferior vena cava.


Recruitment information / eligibility

Status Completed
Enrollment 80
Est. completion date
Est. primary completion date July 2016
Accepts healthy volunteers No
Gender Both
Age group 41 Years to 68 Years
Eligibility Inclusion Criteria:

- tumor size is more than 5cm in diameter;

- these tumor were close to or were compressing main hepatic veins and RIVC directly;

- Pugh-Child Grade is A or Indocyanine green retention rate at 15min (ICG15%) is less than 10% .

Study Design

Observational Model: Case-Only, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Intervention

Procedure:
stepwise vascular control
Before liver parenchymal resection, we performed "total hepatic vascular preparation for occlusion" with portal triad (PT), infra-hepatic inferior vena cava (IIVC), and supra-hepatic inferior vena cava (SIVC) preparation in order. Then we performed step-by-step vascular occlusion according to the individual bleeding situation.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Tongji Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary blood loss during liver resection duration of operation time Yes
See also
  Status Clinical Trial Phase
Completed NCT04588350 - Clinical Investigation Evaluating a New Autotransfusion Device in Cardiac Surgery N/A
Completed NCT00985920 - Topical Tranexamic Acid for Total Knee Arthroplasty Phase 4
Terminated NCT03954314 - DEPOSITION - Decreasing Postoperative Blood Loss by Topical vs. Intravenous Tranexamic Acid in Open Cardiac Surgery Phase 3
Completed NCT04040023 - Patient Blood Management in Cardiac Surgery N/A
Not yet recruiting NCT05379530 - TEG Use in Children Undergoing Procedures With High Anticipated Blood Loss N/A
Withdrawn NCT05672407 - The Role of Local Tranexamic Acid on Periorbital Oculoplastic Surgery Phase 4
Recruiting NCT03740438 - Modeling of the Hemoglobin Drop in the Uncomplicated Postoperative Course
Completed NCT05708690 - Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery Phase 4
Completed NCT04143373 - Effect of Warm Saline Irrigation on Bleeding in Mandibular Third Molar Surgery N/A
Completed NCT03313583 - French One Day Survey in 2011 - Knowing Our Population of Labile Blood Products Recipients N/A
Completed NCT03952546 - To Evaluate the Safety and Efficacy of the Saline-coupled Bipolar Sealer in Primary Unilateral Total Knee Arthroplasty N/A
Active, not recruiting NCT03426839 - Haemostasis Management of Abdominal Aortic Procedures N/A
Completed NCT05780125 - Effectiveness of Different Fibrinogen Preparations in Restoring Clot Firmness Phase 2
Recruiting NCT06164769 - Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery N/A
Completed NCT04025736 - Arthroscopic Shoulder Surgery With Administration of Intravenous Tranexamic Acid N/A
Recruiting NCT02580227 - Tranexamic Acid in Intertrochanteric and Subtrochanteric Femur Fractures Phase 4
Terminated NCT03160170 - Efficacy of Suction Enabled Retraction Device N/A
Not yet recruiting NCT06414031 - Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery Phase 3
Withdrawn NCT03340116 - Measurement of Blood Volume Loss During Burn Surgery
Completed NCT01475669 - Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery Phase 3